Previous 10 | Next 10 |
Alan Sumler comes from the world of academia and brings that perspective to cannabis investing. Long positions and how he approaches his stock analysis. Psychedelic and cannabis overlap. Medical and historical lens. A rare opinion - Positive on Canada! Playing options, bal...
The Green Giants portfolio lagged benchmarks this month. The biggest drop came when SAFE Banking was once again removed by the senate and not included in the America Competes Act. Investors I speak with remain interested in cannabis but are discouraged by the price action. ...
REIT expert Brad Thomas breaks down why cannabis REITs are an income play and a growth story. Real estate is a big part of the industry; lack of federal legalization affords cannabis REITs a strong opportunity. We discuss the value of licenses, leases, good and bad tenants. Br...
There will be plenty of noise around federal legislation in the coming months. Macro headwinds are subsiding, albeit with some lingering pressure around what inflation will do to consumer spending levels. The lower break-even threshold and seemingly more accommodating regulatory e...
Federal legalization as a catalyst and what happens to valuations if we're years away. Growth industries: Comparing undervalued tech to cannabis stocks. Returning to former growth rates as more states come online with adult-use cannabis. For further details see: Cannabis...
Cannabis REITs - a perennial performance leader over the past half-decade - have been slammed in 2022 amid concerns over tenant financial health given the sharp re-pricing of risk and tighter financial conditions. Owning the "Pharmland" - the physical real estate - had been one of the...
Aggressive M&A has yielded massive growth in revenue, locations, and free cash in FY21. Licenses in 18 states, active retailer in 16 states, and active producer in 14 states. Fantastic regulatory arbitrage opportunity, with a company already succeeding in present market condit...
Top Cannabis ETFs To Watch In June Are you looking for the best marijuana stocks to buy now that the markets have reached new lows? The whole market fell considerably in the third week of trading in June due to recession concerns. Morgan Stanley’s top analysts now say there...
Ted Waller returns to discuss staying bullish but getting more realistic about the cannabis industry. Limited growth rates, margin compression and the need to keep our emotions out of investing. Buying special situations and what stocks are more concerning. For further detai...
Ted Waller returns to discuss staying bullish but getting more realistic about the cannabis industry. Limited growth rates, margin compression and the need to keep our emotions out of investing. Buying special situations and what stocks are more concerning. For further detai...
News, Short Squeeze, Breakout and More Instantly...
Amplify ETF Trust - Amplify Seymour Cannabis ETF Company Name:
CNBS Stock Symbol:
NYSE Market:
2024-01-19 07:30:51 ET The Leading Cannabis ETFs to Consider in 2024 Cannabis ETFs are garnering attention in 2024 as the industry shows promising growth. Key players like MJ, MSOS, and CNBS dominate this sector. These ETFs offer diversified exposure to cannabis-related stocks. This...
2023-10-27 07:30:02 ET Q4 2023’s Cannabis ETF Leaders: Where to Invest The cannabis sector continues to entice investors with its prospects for expansion and financial success as we take on the last quarter of 2023. Cannabis Exchange-Traded Funds (ETFs) have become popular for in...
2023-09-15 07:30:42 ET Top Marijuana ETFs for September 2023 In 2023, the cannabis industry and top marijuana stocks are blazing a trail of exponential growth, presenting investors with a unique opportunity to tap into this flourishing sector. As regulatory landscapes evolve and soc...